Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Please Wait
Applying Filters...
01 2Evonik
02 1Kirsch Pharma
01 1Cream / Lotion / Ointment
02 1Gel
03 1Injectable / Parenteral
01 3Germany
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Dosage Form : Cream / Lotion / Ointment, Gel
Grade : Topical
Application : Topical
Excipient Details : L-Aspartic Acid is widely used in topical dosage forms such as creams, gels, ointments and lotions.
Pharmacopoeia Ref : NA
Technical Specs : Molecular weight: 133.1 g/mol
Ingredient(s) : L-Aspartic Acid
Dosage Form : Cream / Lotion / Ointment, Gel
Grade : Topical
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Brand : L-ASPARTIC ACID
Applications : L-Aspartic Acid is widely used in topical dosage forms such as creams, gels, ointments and lotions.
Pharmacopoeia Ref : NA
Technical Specs : Molecular weight: 133.1 g/mol
Grade : Topical
High-quality raw materials and custom blends for pharma, biopharma, nutrition, veterinary, and cosmetics worldwide.
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Application : Parenteral
Excipient Details : Used as a nitrogen source in cell culture media in upstream. use for vaccines, recombinant proteins, antibodies manufacturing.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : L-Aspartic Acid
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
High-quality raw materials and custom blends for pharma, biopharma, nutrition, veterinary, and cosmetics worldwide.
Brand : L-ASPARTIC ACID
Applications : Used as a nitrogen source in cell culture media in upstream. use for vaccines, recombinant proteins, antibodies manufacturing.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Grade : Biopharma Grade
